HR 4692
Increasing Prescription Drug Competition Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Increasing Prescription Drug Competition Act, aims to lower the cost of prescription drugs by preventing pharmaceutical companies from using patents and trade secrets to block generic drug manufacturers from entering the market. Specifically, it addresses patents related to ‘elements to assure safe use’ (ETASU) within risk evaluation and mitigation strategies (REMS) programs, ensuring that generic drug approvals aren’t delayed by these patents. The bill also limits the legal remedies available to brand-name drug sponsors when facing patent infringement claims from generic competitors, focusing solely on monetary damages.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.